UNSPSC 51121920: Sulmazole

This classification denotes a cardiotonic agent with the molecular formula C14H13N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HK56EH9K44, chemically known as 2-(2-methoxy-4-(methylsulfinyl)phenyl)-1h-imidazo(4,5-b)pyridine but generally known as sulmazole, which bears US NIH Compound Identifier 5353. European Medicines Agency schedules Sulmazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10748MIG.

UNSPSC 51121920 Sulmazole is a Commodity code covering pharmaceutical active ingredients and finished medications procured by state and local health agencies, emergency services, and cooperative purchasing consortia. State and local governments buy sulmazole and related advanced life support medications under this code through sealed competitive bids and cooperative purchasing vehicles. The City of Tampa's Fire Rescue division, for example, recently solicited advanced life support medications including epinephrine, labetalol, adenosine, and diltiazem through an IFB (Bid No. 26-P-00188) with a $40,000 estimated contract value and a Small Local Business Enterprise sheltered-market set-aside offering a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers and certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. Issuing bodies include municipal fire and emergency medical services departments, state health and human services agencies, and multi-state cooperative purchasing alliances serving health-care facilities and government employee benefit programs.

Recent activity concentrates in Florida and Minnesota, with Texas Health and Human Services Commission exploring direct-to-manufacturer prescription fulfillment models through an RFI posted in March 2026. The City of Tampa's April 2026 IFB sought four specific medication line items with nine-month minimum shelf life, delivery within ten calendar days, and a one-year contract term renewable for two additional years; bids were due April 8, 2026, through the OpenGov eProcurement Portal. The MMCAP RFP, due March 26, 2026, established a two-year contract term for new vendors with evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing structure, and the remainder on administrative compliance and EDI capability; awarded vendors would be provided to wholesalers by May 15, 2026, with contracts effective July 1, 2026. Solicitations under this code typically require vendors to supply National Drug Codes with specific NDC, SKU, and UPC data; maintain comprehensive insurance including commercial general liability of $2 million to $5 million; comply with FDA and OSHA requirements; and provide Safety Data Sheets and accessibility documentation.